Amesite Announces Successful Soft Rollout of NurseMagic™ Caregiver Solution, Expanding Its Addressable Market for Enterprise by 50%
Rhea-AI Summary
Amesite (NASDAQ: AMST) announced successful early adoption of its non-clinical caregiver tool in NurseMagic™, an AI-driven solution supporting non-clinical healthcare workers. The expansion targets home health care and skilled nursing segments, effectively increasing its enterprise addressable market by 50%, reaching over 1.5 million non-clinical healthcare support workers in the U.S.
Key achievements include:
- Hospice provider contracts growth of over 3,000% in the last three months
- Contract sizes increase of nearly 1,000%
- Implementation of automated purchase process for faster contract expansion
The NurseMagic™ solution aims to reduce management intervention needs while improving documentation, communication, and patient care. The company's proprietary AI infrastructure is HIPAA-compliant and designed for rapid training and accuracy, with plans to introduce new tools in the coming months based on customer engagement and market needs.
Positive
- 3,000% growth in hospice provider contracts over last 3 months
- 1,000% increase in contract sizes
- 50% expansion in addressable enterprise market
- Automated purchase process implementation reducing sales cycle
- HIPAA-compliant AI infrastructure
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, AMST gained 4.61%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Amesite's Proprietary AI Powers Caregiver Solution Enables Contract Growth in Large Segments
DETROIT, March 11, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, today announced the early adoption of its non-clinical caregiver tool in NurseMagic™. The Caregiver NurseMagic™ Solution directly supports non-clinical workers in their day-to-day jobs, reducing the need for intensive intervention by management, and improving documentation, communication and patient care.
Amesite sales are focused on home health care and skilled nursing. Agencies and corporations in these segments employ both clinical and non-clinical staff. Broadly, there are almost 3 million home health care and skilled nursing staff in the U.S., of which over 1.5 million are non-clinical healthcare support workers. By expanding NurseMagic™ solutions to meet the needs of non-clinical workers, Amesite estimates that it has expanded its addressable market for enterprise sales alone by around 50%.
Amesite reports that an increasing number of customers have adopted NurseMagic™ for their entire teams, which include non-clinical staff such as CNAs, chaplains, social workers and nurse aides. Over the last three months, Amesite reported that its contracts with hospice providers have grown by over 3,
Brandon Owens, VP of Sales at Amesite, stated, "We are accelerating contract closures, increasing deal sizes, and expanding existing agreements with a growing suite of features. Organizations that deploy our platform across their entire workforce realize a disproportionate advantage—dramatically reducing audit risk and operational costs. By delivering the right NurseMagic™ solution to every employee, we empower agencies and corporations to seamlessly scale their contracts to cover
Kalie Wortinger, Senior Manager of Engineering, said, “We built our infrastructure to be able to train our proprietary AI with extreme speed and accuracy, while meeting HIPAA requirements. We plan to roll out several new tools in the coming months to address market needs, informed by engagement with a rapidly growing cohort of customers and sales prospects.”
Amesite CEO Dr. Ann Marie Sastry stated, "We firmly believe that AI will ultimately support
About Amesite Inc.
Amesite (NASDAQ: AMST) is an AI-driven company with an immediate aim to transform the
Forward-Looking Statements
This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
Investor Relations
ir@amesite.com
Sources
- https://www.bls.gov/oes/2023/may/oes310000.htm
- https://www.statista.com/statistics/185249/persons-employed-in-home-health-care-services-in-the-us-since-2000/
- https://www.bls.gov/oes/2023/may/naics4_623100.htm